As Executive Vice President of Market Access and Customer Solutions at PhyzData, Mike provides business strategies of all portfolio management. Within his roles, he ensures the success of the widest variety of strategic projects across departmental segments, applies strategic business development, contract negotiations, network development, marketing & outreach strategies, and other business development initiatives that cultivate opportunities that affect client segments. Identify pressing market factors and drive strategic business strategy for all facets related to the specialty market.
With more than 19+ years of pharmaceutical and biotech industry experience, including roles in national and regional managed markets, specialty supply channels, sales management and specialty brand management, Mr. Baldzicki offers strategic insight into specialty pharmacy trends, distribution, contracting, reimbursement, and the application of health outcomes and economic evidence to prove value proposition. He is a recognized leader in the specialty pharmaceutical market for developing and implementing key payer and specialty pharmacy agreements that result in documented savings for specialty market segments.
Mr. Baldzicki held roles in senior executive management within the specialty pharmacy supply group, pharmaceutical and biotech industry of managed markets, group purchasing organizations, specialty wholesale, and integrated delivery networks. He assumed roles within the pharmaceutical organization such as Bayer Healthcare, Bristol-Myers Squibb, Enzon BioTech, Baxter BioScience, as well as roles within the distribution channel of AmerisourceBergen specialty groups, Diplomat/BioRx Specialty Pharmacy, Armada Health Care, to other manufacturer & specialty pharmacy home infusion companies. He brings particular expertise in business development, managed markets, specialty pharmacy, hospital systems, reimbursement, and brand management for biologics, including specialty infusion therapies for bloods products, hematology, oncology, and other rare orphan drugs.
Mr. Baldzicki is active in the biotech community and is an Advisor/Faculty member of the Academy of Managed Care Pharmacy (AMCP) for Specialty Pharmacy Advisory Group & Biosimilars Partnership Forum, Faulty Board Member of the American Journal of Managed Care (AJMC) Specialty Pharmacy for ACOs, Guidepoint Global Committee Member for Specialty Pharmacy, and was 2014 Editorial Board Member for Specialty Pharmacy Times.
Mr. Baldzicki has published abstracts and articles surrounding plasma-based infusion therapy, managed markets, and specialty pharmacy. He has spoken at a variety of seminars and WebEx’s within specialty groups and other industry-related settings.
Mr. Baldzicki holds a Bachelor of Arts in Business Management and a Certificate in Clinical Research Compliance and Management (CRCM). He has completed programs in leadership development at Harvard University, Quantum management, Brooks Group, Miller Heiman Account Management, and MD Anderson Center Cancer Courses.
Melissa Benson leads the National Health Systems Management (HSM) Team at Genentech that focuses on partnering with major health systems to evaluate the most effective ways to optimize their stroke programs.
Melissa has had an extensive sales career in Biotech/Pharma for over 20 years with 18 of those years being with Genentech. Beyond being recognized for consistently exceeding her sales goals a few noteworthy achievements include the following:
She created a strategic hospital relationship mapping and decision-making tool known as S.H.A.P.E. to better equip sales representatives in a complex selling environment.
She is also passionate about corporate culture and the power of engaged employees at all levels. This inspired her to spearhead a field leadership program anchored on individual choice, transparency and recognition.
Melissa grew up in the Metro Detroit area where she became familiar with suburbia, strip malls and soccer. Despite having 3 generations of University of Michigan grads in her family, she chose to attend Michigan State University. While she is a Spartan at heart, it is noted that she is no longer invited to any family gatherings.
She has two amazing kids, Jack (10) and Avery (8), that she affectionately refers to as “Team Chaos.” When she is not having fun running around with “Team Chaos” she enjoys anything active and trying new wines.
Currently working for Aralez Pharmaceuticals US Inc. as the Executive Director Managed Markets with responsibility in all aspects of Trade and Distribution. Prior to this position, I was Director of Trade, Reimbursement and Access at Vanda Pharmaceuticals Inc. where I was able to build a Specialty Distribution Network and launch the companies first Orphan Medication. Along with these two positions, I have more than 25 years of experience in the Pharmaceutical and Biotech Industry in a number of roles in Managed Markets, Sales and Marketing.
Kim Coppom has more than 30 years of pharmaceutical and biotech experience. She currently is the Senior Director, Market Access | West at Sobi, Inc, a Swedish rare disease company dedicated to providing access to innovative treatments for patient with rare diseases. In this position, Kim is responsible for the Market Access Organization in the West overseeing National and Regional Account Management, Specialty Pharmacies and Field Reimbursement.
Prior to joining Sobi, Inc, Kim has held various senior level leadership positions at Intarcia Therapeutics, AstraZeneca, BMS and Sanofi. She has a broad range of experience and expertise leading sales and market access teams within the industry. Kim is passionate about identifying intersections that create value for patients and those that serve them.
Michele A Forgues Fisher, MBA, MBA, FACHE, FACMPE, CHFP is Chief Contracting and Payer Relations Officer of UW (University of Washington) Medicine Health System. Michele has over 30 years’ experience in health care leadership positions in various business development, revenue cycle focused, operational, and clinical roles.
She is accountable for, among other items, the actuarial relationships for UW Medicine and the negotiation process of all types payer contracts and all aspects of payer or employer contract reporting for all UW Medicine entities and business development ventures and partenrships.
Michele is a Fellow in the American College of Healthcare Executives (FACHE), a Fellow in the American College of Medical Practice Executives (FACMPE) of the Medical Group Management Association (MGMA), a Certified Specialist in Managed Care (CSMC) and Certified Healthcare Financial Professional (CHFP) for HFMA, and, until Fed, 2017 was CoC and CPC-h certified by AAPC (American Academy of Professional Coders), Additionally Michele is Member of the American medical Group Association (AMGA) and the Washington Medical Association (WMA).
Michele was an Executive Certification in Advanced negotiations for the University of Notre Dame. She graduated from Taft University W. Edwards Deming School of Business with honors (Magna Cum Laude) with an MBA with an emphasis in Healthcare Administration.
Robert Guigley is an experienced market access and strategic development leader with 15 years of experience in the biotechnology industry. He is currently Vice President of Market Access for Ambry Genetics where he leads a team of professionals partnering with regional and national health plans to manage coverage agreements and network relationships that provide access to Ambry’s testing to hundreds of millions of members nationwide. Guigley joined Ambry from innovative digital health company Omada Health, where he served as Vice President of Sales, Health Plans and Reimbursement Strategy. Before that, he held sales and market access positions at Quest Diagnostics and Counsyl, the latter of which he served as Vice President of Health Plans. Guigley earned his MBA at Boston University Questrom School of Business and his BS at the University of Pittsburgh, where he focused on economics, math and philosophy.
Elizabeth Johnson is currently the Biologics Coordinator at Allergy Partners, P.A., the largest single-specialty group in the United States. She is also the CEO and Principal Consultant at 5015 Consulting. Elizabeth is a Licensed Practical Nurse (LPN) with a rich background in patient care and holds the Certified Professional Coder (CPC) designation, exemplifying her knowledge of the billing and coding side of medicine. Combining these two areas with her love of training, Elizabeth has been able to successfully and consistently educate physician practices on various methods of acquisition for biologics and biosimilar medications. Her efforts have resulted in millions of dollars of unrecognized revenue for medical practices across the US, all while maintaining the patient as the highest priority. When not at work, Elizabeth enjoys spending time with her wonderful husband and two beautiful children, reading, and traveling.
Adam is currently working within the Corporate Market Access, Customer Value Group at Boehringer Ingelheim in Ingelheim, Germany, as a Head of Strategic Market Access Initiatives. In his role, he is responsible for orchestrating and piloting the strategic customer collaboration initiatives and helping to optimise market access excellence standards and processes within the Organisation.
Adam has started his career with Boehringer Ingelheim in 2012 as a Senior Global Payer Strategy Manager working in oncology and HCV in Ingelheim, Germany. He was managing global pricing and market access strategies for the HCV and oncology portfolio and driving the development of innovative market access approaches and payment schemes. He then moved to the UK and Ireland Organisation in 2015 to Head the Pricing and Contracting Team, working across the whole Boehringer Ingelheim prescription medicines portfolio.
Prior to joining Boehringer Ingelheim, Adam worked as a life sciences strategy consultant for IMS Consulting, Truven Analytics and Simon-Kucher & Partners in Belgium, France, Germany, Poland, Romania and The United States. He also worked as a research assistant at Jules Gonin Eye Hospital in Lausanne, Switzerland and as a Junior Project Leader at AnalyCen in Poland and Sweden.
Adam holds an M.Sc. in Molecular Biology and Biotechnology from University of Warsaw, Poland, and a Ph.D. in Neurosciences from University of Geneva, University of Lausanne and EPFL, Switzerland. He has published several articles in international peer-reviewed journals and lectured at international conferences on developmental neuroscience and retinal degeneration.
Joshua M. Liao, MD, MSc, FACP, is a board-certified internal medicine physician and the Medical Director for Payment Strategy at UW Medicine, where he is also the Director of the Value and Systems Science Lab, a unit that applies scholarship to drive change that impacts patients, populations, and health system organizations. He holds faculty appointments in both the Schools of Medicine and Public Health at the University of Washington.
Dr. Liao’s expertise includes policy analysis related to value-based payment and care delivery reforms, with scholarly work focusing on evaluating and testing the impact of value-based payment and delivery reforms on patients, physicians, and health care organizations. Through leadership on system-wide efforts evaluating the organizational impact of payment reforms, he also has expertise in value-based organizational strategy, in particular in how to implement teams, structures, and tools to achieve value-based care goals.
His work is these areas has appeared in a number of forums, including peer-reviewed journals such as The New England Journal of Medicine, Health Affairs, The Journal of the American Medical Association, The Lancet, and The Annals of Internal Medicine, as well as non-peer-reviewed forums such as The Harvard Business Review, The Washington Post and The Boston Globe, among others. He is also an Associate Editor for Healthcare: The Journal of Delivery Science and Innovation, a journal committed to assisting health system leaders, policymakers, and other stakeholders to improve care via cutting-edge research on innovation in healthcare delivery, systems and process improvement, management, and applied information technology.
Dr. Liao received a Bachelor of Arts in English literature and a Bachelor of Science in biochemistry and cell biology from Rice University and his medical degree from Baylor College of Medicine. He completed his residency in internal medicine at Brigham & Women’s Hospital where he was also a Clinical Fellow in Medicine at Harvard Medical School. He is an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics located at the University of Pennsylvania, where he received his training in health policy research.
Susan Malecha has more than 24 years of pharmaceutical/biotechnology industry experience in medical affairs, new product development, managed markets, medical education, medical science liaisons and management. She graduated with a B.S. in pharmacy from Butler University, completed her Doctor of Pharmacy at University of Illinois at Chicago, and earned her Masters of Business Administration from Keller Graduate School of Management. She recently completed the certificate program for Pharmacoeconomics Health and Outcomes Research at University of Washington. She currently is a National Lead, Managed Care Liaison in Medical Affairs at Genentech, supporting Kaiser, Department of Defense, Veterans Administration and other accounts. She was recently the Senior Director, BioOncology Medical Science Liaisons at Genentech. Prior to her biotech positions, Susan was the Senior Director of a clinical field-based team, Director of Managed Care of a field based-medical team and the Director of Medical Education at a large pharmaceutical company.
Susan is an active member of HBA, a former Executive Board Member/Director of Membership for the Southern California Chapter of HBA (2012) HBA Mentoring Program Lead, So. Cal Chapter (2014), and a part of the HBA Field Chapter Advisory Council for Genentech (2014-2015). She is an active presenter/lecturer on medical affairs topics for pharmaceutical industry. She has published papers in Pharmacotherapy, Drug Information Journal, MSL Quarterly, DIA Forum, American Journal of Managed Care Pharmacy and American Journal of Pharmaceutical Education. She published a book, Bridging Scientific Knowledge: The Role of the Medical Science Liaison, in 2009, and she contributed a chapter to Erin Albert’s 2008 book and 2011 e- book, Medical Science Liaisons A to Z.
John Marchica is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University. He is leading ongoing, in-depth research initiatives on Accountable Care Organizations, Integrated Health Systems, and value-based care. John is also the founder and CEO of Darwin Research Group, a healthcare market analytics firm specializing in health care delivery systems.
John began his career at SRG as a health systems analyst, followed by a successful stretch in general management at Abbott Laboratories. He’s a two-time healthcare entrepreneur, and his first company, FaxWatch, was listed twice on the Inc. 500 list of fastest-growing American companies. John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade.
John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He serves as an active member of the American College of Healthcare Executives and is an advisor to the Global Council on Alzheimer’s Disease.
Martin Marciniak, RPh, MPP, PhD is Vice President, US Medical Affairs responsible for Customer Engagement, Value, Evidence and Outcomes and the interim head for the US Respiratory therapeutic area within GlaxoSmithKline. His leadership and research experience has included specific therapeutic area focus in oncology, neuroscience, cardiovascular disease, policy and economics. He has published in peer-reviewed journals and has been invited to present clinical, health outcomes, and economic results at both national and international meetings. In addition to his research activities, Martin has previously served as a nonvoting industry representative to the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) for the Centers for Medicare and Medicaid Services and as a board member for the National Pharmaceutical Council (NPC) Board of Directors. Presently, he serves as a member of the National Quality Forum Efficiency Steering Committee, the Editorial Advisory Board for Value and Outcomes Spotlight (an ISPOR publication), and on the advisory board for the Institute for Clinical and Economic Review (ICER). Martin has also served the broader healthcare community in several different ways, most recently through invitations to engage in public forum discussions at SCOPE, Eye for Pharma, BioCentury TV and the FDA/CMS Summit.
Martin holds a position of Adjunct Assistant Professor in the Division of Pharmaceutical Outcomes and Policy at the University of North Carolina’s Eshelman School of Pharmacy. He received his Ph.D. from the University of California at Berkeley, his masters’ degree in Public Policy from Harvard University, and his BS in Pharmacy from Purdue University.
Mr. Oldroyd has over twenty five years of experience in the healthcare industry. His focus is commercialization of new products and services nationally, working with biopharma, lab, device and equipment start ups. He has created multiple successful pricing and launch strategies. His education includes a J.D. specializing in health law and policy. When not traveling for work, you will find him logging 8-10 thousand miles a year as an avid motorcyclist.
Steven Pitts is the Senior Director, Payer Accounts leading a team of National and Regional Account Managers at Jazz Pharmaceuticals. He has spent the last 23 years of his pharma career in the market access space, encompassing the roles of Regional and National Account Director and Managed Markets Business Unit Director at Zeneca Pharmaceuticals; Regional Director for Managed Markets, Managed Markets Field Readiness Leader for Crestor launch and Contracting Director at AstraZeneca, Regional and National Field Director for Payer and Institutional Accounts at Sunovion Pharmaceuticals; and Senior Director, Corporate Accounts at CSL Behring prior to joining Jazz in 2015. His work has included the areas of Payers, Specialty Pharmacies and Distributors, GPO’s, IDN’s, Retail, Wholesale and supply chain management across a wide variety of therapeutic areas.
Joseph Rogers, PharmD, MS is the Director of Specialty Pharmacy at Memorial Hermann Health System in Houston, Texas. He completed his Doctor of Pharmacy at The University of Kansas. He completed a combined PGY1/2 Health System Pharmacy Administration residency at Memorial Hermann and a Master of Science in Pharmacy Leadership and Administration at the University of Houston. He has published on the use of Big Data in health system pharmacy, health system pharmacy leadership, and the topic of inpatient drug distribution and administration. Joseph is the Immediate Past President of the Gulf Coast Society of Health System Pharmacists and serves on the Public Affairs committee for the Texas Society of Health System Pharmacists. His professional interests include specialty disease state management, transitions of care, and demonstrating the pharmacy profession’s value in the environment of healthcare reform.
Scott Sorenson is the currently the Director, Specialty Managed Care at Paragon Healthcare, Inc. whose home office is located in Charlotte, NC.
Scott started his career as a Home Health Administrator, where he oversaw the operations of Medicare and Medicaid home health services (HHA, RN, PT, OT, ST) and learned the importance of the referral, intake and authorization processes under the CMS- II regulations and JCAHO accreditations.
Scott began diversifying his experience when his employer acquired a home infusion service. Post-acquisition Scott worked for Accredo/Medco for 13 years as a hemophilia health account manager and then progressed to a National Account Manager for managed Medicaid payers; where he established his expertise in the growing complexities of onboarding patients. A move to BioRx/Diplomat, for 5 years, as Director, Medicaid and Government Services, where his subject matter expertise continued to develop within the State/Federal Governments’ deployment and implementation of regulatory and legislative actions; thus developing administrative tools that reached CMS, MEDPAC, MACPAC, HCPLAN, Medicare part B/DMEPOS and part D MACs and PDPs.
Scott has been with Paragon Healthcare, Inc. since May 2017 and continues his career with PBM/PSAO credentialing, Government payer applications, contract execution and implementation specific to Paragon Healthcare’s specialty pharmacies.
Dr. Richard Stefanacci has focused his career on care delivery systems to improve health outcomes. He has put this focus into practice as chief medical officer (CMO) for several management care plans including ElderHealth/Bravo/HealthSpring/Cigna and PACE (Program for All-inclusive Care for the Elderly) programs. Despite being a CMO, Dr. Stefanacci throughout has maintained active clinical practice focused on frail older adults knowing the importance of leading change directly with his care teams.
On the policy side, Dr. Stefanacci served as Health Policy Scholar for the Centers for Medicare & Medicaid Services (CMS) through his role at Thomas Jefferson University, College of Population Health where is maintains a faculty appointment. He has over 500 publications in addition to delivering well over 1000 lectures both nationally and internationally focused on efficient and effective care delivery.
An active member of several professional associations focused on care delivery – Dr. Stefanacci served on the American Society of Consultant Pharmacists (ASCP) and the AMDA Foundation Boards as well as being honored as an honorary lifetime member for ASCP and the National Association of Directors of Nursing. Finally, Dr. Stefanacci has achieved recognition as a fellow in both the College of Physicians of Philadelphia and American Geriatric Society as well as recently being awarded the Humanism in Aging Leadership Award from the University of New England, Department of Geriatrics.
Dr Stefanacci’s greatest accomplishment is the Go4theGoal Foundation (www.Go4theGoal.org), a 501(c)(3) public charity that he founded with his family and friends when his oldest son Richard was diagnosed with Ewing’s sarcoma in May 2006. He developed the foundation with an intense focus after his son’s death on June 12, 2007. Since its inception, the foundation has raised several million dollars to assist hundreds of children affected by cancer at nearly 100 children’s hospitals across the country, while also funding cutting-edge research to find a cure – again focused on improving care outcomes.
Jennifer is the Senior Manager of Cannabinoid Education for Greenwich Biosciences. Prior to her current role, Jennifer was a Medical Science Liaison at Greenwich Biosciences providing scientific support to develop an FDA-approved cannabidiol therapy for the treatment of seizures associated with epilepsy. Jennifer received her Masters of Science from State Cloud State University examining steroid hormones in female rugby athletes and her PhD at the University of Minnesota examining sex differences in cancer pain. Before graduate school, she spent several years working in academia performing laboratory research focused on neuroendocrinology. She currently lives in Minneapolis with her spouse, 2 children, and a fish named ‘Pete’.
Pritpal Virdee is the President of Medicare Holdings, a newly formed business unit within Emergent Holdings, a for profit subsidiary of Blue Cross Blue Shield of Michigan. Medicare Holdings is focused on building strategic Blue-to-Blue joint venture partnerships with the purpose of growing the Medicare Advantage footprint in Blue States across the nation. In his role he is responsible for overseeing profitability, operations, growth, and strategy.
Most recently, Pritpal as Senior Vice President and Chief Operating Officer led the operational areas across all BCBSM’s Medicare product lines, fostering a strong matrix partnership across key operational functions. Previously, Pritpal held the position of Health Plan President, Medicare –Indiana, Kentucky and Missouri at Anthem Inc, holding profit and loss responsibility for all Medicare products within the regions.
He has also served in key leadership roles at Walgreens and Express Scripts. Pritpal earned a Bachelor of Science degree in Chemical Engineering from Southbank University in London, England and a Diploma in Marketing from the Institute of Marketing in the United Kingdom.